GPP2 Guidelines, 2009
To address legislative, guidance, and ethical developments since 2003, and to reinforce the aims of the original 2003 publication, the International Society for Medical Publication Professionals (ISMPP) convened a Steering Committee to develop a revised Good Publication Practice document which is now known as “GPP2”.
The Committee’s work, GPP2, was independently peer reviewed and published:
Graf C, Battisti WP, Bridges D, et al. for the International Society of Medical Publication Professionals. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ 2009;339:b4330.
BMJ article online
PDF of BMJ article
GPP2 provides comprehensive guidance on a number of key issues, including:
Roles of authors, sponsors, and other contributors
Reimbursement and honoraria
How to establish a publication steering committee
Role of professional medical writers
Recommendations for publication planning and documentation
GPP2 presentation by Chris Graf
Click here to view.
The Medical Roundtable
ISMPP thanks The Medical Roundtable for allowing ISMPP members to download "GPP2: Good Publication Practices for Sponsored Medical Research: Elevating the Integrity of Scientific Communications." Click here to read the article.
Frequently Asked Questions
Click here to view.
GPP Historical Archive
GPP Guidelines, 2003
The landmark guidelines on Good Publication Practice (GPP) published in 2003 were developed with the aim of ensuring that “clinical trials sponsored by pharmaceutical companies are published in a responsible and ethical manner."
Wager E, Field EA, Grossman L. Good publication practice for pharmaceutical companies.Curr Med Res Opin 2003;19:149-154.
PDF of CMRO article
Click here to read the Editorial that accompanied the original GPP
Click here to view the GPP Working Group
Click here for background notes on GPP
Back to top
GPP2 Article in BMJ
GPP2 press release
GPP2 Steering Committee